Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Kishikawa, Takahiro ^a   Otsuka, Motoyuki ^a,b   Yoshikawa, Takeshi ^a   Ohno, Motoko ^a   Takata, Akemi ^a   Shibata, Chikako ^a   Kondo, Yuji ^a   Akanuma, Masao ^c   Yoshida, Haruhiko ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICRORNA;

3' UNTRANSLATED REGION; ANIMAL; ARTICLE; BASE PAIRING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC PREDISPOSITION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; MOUSE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE PAIRING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER NEOPLASMS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; RNA INTERFERENCE;

EID: 84884932181     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02739     Document Type: Article

References (28)

1. El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264-1273 (2012).
2. Sherman, M. Hepatocellular carcinoma: New and emerging risks. Dig Liver Dis 42, S215-222 (2010).
3. Arzumanyan, A., Reis, H. M. & Feitelson, M. A. Pathogenic mechanisms in HBVand HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13, 123-135 (2013).
4. Urabe, Y. et al. A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region. J Hepatol (2013).
5. Kumar, V. et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43, 455-458 (2011).
6. Kumar, V. et al. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLoS One 7, e44743 (2012).
7. Maccalli, C., Scaramuzza, S. & Parmiani, G. TNK cells (NKG2D1 CD81 or CD41 T lymphocytes) in the control of human tumors. Cancer Immunol Immunother 58, 801-808 (2009).
8. Jinushi, M. et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 43, 1013-1020 (2005).
9. Diefenbach, A., Jensen, E. R., Jamieson, A. M. & Raulet, D. H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165-171 (2001).
10. Hayakawa, Y. Targeting NKG2D in tumor surveillance. Expert Opin Ther Targets 16, 587-599 (2012).
11. Guerra, N. et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28, 571-580 (2008).
12. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 285, 727-729 (1999).
13. Eleme, K. et al. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J Exp Med 199, 1005-1010 (2004).
14. Yadav, D., Ngolab, J., Lim, R. S., Krishnamurthy, S. & Bui, J. D. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gammainduced microRNA. J Immunol 182, 39-43 (2009).
15. Stern-Ginossar, N. & Mandelboim, O. An integrated view of the regulation of NKG2D ligands. Immunology 128, 1-6 (2009).
16. Janssen, H. L. et al. Treatment ofHCV Infection by TargetingMicroRNA. NEngl J Med 368, 1685-94 (2013).
17. Salih, H. R., Rammensee, H. G. & Steinle, A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169, 4098-4102 (2002).
18. Tang, K. F. et al. Decreased Dicer expression elicits DNA damage and upregulation of MICA and MICB. J Cell Biol 182, 233-239 (2008).
19. Takata, A. et al. MicroRNA-22 and microRNA-140 suppress NF-kB activity by regulating the expression of NF-kB coactivators. Biochem Biophys Res Commun 411, 826-831 (2011).
20. Yoshikawa, T. et al. Silencing of microRNA-122 enhances interferon-a signaling in the liver through regulating SOCS3 promoter methylation. Sci. Rep. 2, 637 (2012).
21. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
22. Gazit, R. et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7, 517-523 (2006).
23. Lo, P. H. et al. Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk. PLoS One 8, e61279 (2013).
24. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010).
25. Elmén, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
26. Kojima, K. et al.MicroRNA122 is a key regulator of a-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2, 338 (2011).
27. Takata, A. et al. MicroRNA-140 acts as a liver tumor suppressor by controlling NF-kB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology 57, 162-170 (2013).
28. Kru?tzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005). Technology